Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Fagan

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Journal of Medical Virology|January 1, 1989
Viruslike particles in liver in sporadic non-A, non-B fulminant hepatitisE A Fagan, D S Ellis, G M Tovey, et al.
Journal of Hepatology|January 1, 1986
An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infectionP Guarascio, A P De Felici, D Migliorini, et al.
Journal of Virological Methods|December 1, 1985
Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the spot hybridization technique and scintillation countingE A Fagan, P Guarner, S D Perera, et al.
Journal of Medical Virology|January 1, 1987
Controlled clinical trial of acyclovir in chronic hepatitis B virus infectionG J Alexander, E A Fagan, J E Hegarty, et al.
Journal of Hepatology|January 1, 1986
A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patientsG J Alexander, E A Fagan, P Guarner, et al.
Journal of Medical Virology|February 1, 1988
Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phaseJ Brahm, S Vento, E G Rondanelli, et al.
The Quarterly Journal of Medicine|February 1, 1991
Detection of hepatitis B virus DNA sequences in liver in HBsAg seronegative patients with liver disease with and without anti-HBc antibodiesE A Fagan, F D Davison, R Trowbridge, et al.
Journal of Medical Virology|July 1, 1989
Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-BE A Fagan, D S Ellis, G M Tovey, et al.
Journal of Hepatology|January 1, 1986
Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacyG J Alexander, E A Fagan, N Rolando, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Association of a precore genomic variant of hepatitis B virus with fulminant hepatitisW F Carman, E A Fagan, S Hadziyannis, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Journal of Medical Virology|January 1, 1989
Viruslike particles in liver in sporadic non-A, non-B fulminant hepatitisE A Fagan, D S Ellis, G M Tovey, et al.
Journal of Hepatology|January 1, 1986
An open study of human lymphoblastoid interferon and oral acyclovir in chronic hepatitis B virus infectionP Guarascio, A P De Felici, D Migliorini, et al.
Journal of Virological Methods|December 1, 1985
Quantitation of hepatitis B virus DNA (HBV DNA) in serum using the spot hybridization technique and scintillation countingE A Fagan, P Guarner, S D Perera, et al.
Journal of Medical Virology|January 1, 1987
Controlled clinical trial of acyclovir in chronic hepatitis B virus infectionG J Alexander, E A Fagan, J E Hegarty, et al.
Journal of Hepatology|January 1, 1986
A controlled trial of 6 months thrice weekly lymphoblastoid interferon versus no therapy in chronic hepatitis B virus infection. A preliminary analysis of the first 32 patientsG J Alexander, E A Fagan, P Guarner, et al.
Journal of Medical Virology|February 1, 1988
Sequential studies of pre-S2 antigenemia and anti-pre-S2 antibodies in relation to viral replication in acute hepatitis B followed from the early incubation phaseJ Brahm, S Vento, E G Rondanelli, et al.
The Quarterly Journal of Medicine|February 1, 1991
Detection of hepatitis B virus DNA sequences in liver in HBsAg seronegative patients with liver disease with and without anti-HBc antibodiesE A Fagan, F D Davison, R Trowbridge, et al.
Journal of Medical Virology|July 1, 1989
Toga-like virus as a cause of fulminant hepatitis attributed to sporadic non-A, non-BE A Fagan, D S Ellis, G M Tovey, et al.
Journal of Hepatology|January 1, 1986
Differential effect of ARA-AMP on serum DNA polymerase activity and serum HBV-DNA in chronic hepatitis B virus infection. A possible reason for lack of efficacyG J Alexander, E A Fagan, N Rolando, et al.
Hepatology (Baltimore, Md.)|August 1, 1991
Association of a precore genomic variant of hepatitis B virus with fulminant hepatitisW F Carman, E A Fagan, S Hadziyannis, et al.
Pageof 7